Cheviot Value Management LLC Buys Shares of 4,100 Cardinal Health, Inc. $CAH

Cheviot Value Management LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 4,100 shares of the company’s stock, valued at approximately $667,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. SJS Investment Consulting Inc. lifted its position in Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after buying an additional 150 shares during the last quarter. Atlantic Edge Private Wealth Management LLC raised its stake in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after acquiring an additional 75 shares during the period. Vermillion & White Wealth Management Group LLC raised its stake in shares of Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the period. American Capital Advisory LLC lifted its holdings in shares of Cardinal Health by 5,200.0% in the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock worth $33,000 after acquiring an additional 208 shares during the last quarter. Finally, NewSquare Capital LLC boosted its position in shares of Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after purchasing an additional 107 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CAH. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and boosted their target price for the company from $190.00 to $244.00 in a research report on Friday, January 9th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday. Leerink Partners set a $240.00 target price on Cardinal Health in a research note on Tuesday, January 13th. Evercore ISI raised their target price on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Finally, Mizuho set a $222.00 price target on shares of Cardinal Health in a research note on Monday, January 12th. Fourteen research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $221.07.

View Our Latest Stock Analysis on Cardinal Health

Cardinal Health Price Performance

CAH stock opened at $208.29 on Friday. The business’s 50-day moving average is $205.78 and its two-hundred day moving average is $176.26. The firm has a market capitalization of $49.49 billion, a P/E ratio of 31.42, a P/E/G ratio of 1.41 and a beta of 0.65. Cardinal Health, Inc. has a 1 year low of $120.72 and a 1 year high of $215.48.

Cardinal Health (NYSE:CAHGet Free Report) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.